Add Company
Join Now

Cybergenetics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cybergenetics's estimated annual revenue is currently $3.3M per year.(i)
  • Cybergenetics's estimated revenue per employee is $155,000

Employee Data

  • Cybergenetics has 21 Employees.(i)
  • Cybergenetics grew their employee count by 5% last year.

Cybergenetics's People

NameTitleEmail/Phone
1
CSO and CEOReveal Email/Phone
2
DNA AnalystReveal Email/Phone
3
Forensic CoordinatorReveal Email/Phone
4
Forensic AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Cybergenetics?

Cybergenetics TrueAllele® technology interprets DNA data from crime scene evidence. Laboratories, investigators and lawyers want accurate unbiased results. But some methods limit DNA interpretation, giving inaccurate answers. TrueAllele provides a solution. TrueAllele technology is automated and objective. Its robust software interprets "inconclusive" DNA. The computer uses all the DNA data. And it quickly and reliably solves DNA mixtures. TrueAllele separates DNA mixture data into genotypes. Afterwards, the computer determines how strongly evidence matches a person, or even other evidence. The statistical results help with investigative leads and in legal proceedings. Validation studies show that TrueAllele results are reliable. Courts accept the computer findings in the United States and abroad. Cybergenetics offers forensic DNA education and other resources. Ask about a free TrueAllele screening of DNA case data.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.2M21-34%N/A
#2
$15M215%N/A
#3
$3M21-22%N/A
#4
$2.1M21-16%N/A
#5
$1.5M2131%$2.5M